CLL2HV Study

The CLL2HV study is a clinical trial focused on treating chronic lymphocytic leukemia (CLL), a type of cancer that affects the blood and bone marrow. The study investigates the effectiveness of a specific treatment regimen that combines a drug called venetoclax with traditional chemotherapy. Researchers aim to determine if this combination improves patient outcomes, such as remission rates and overall survival. The study's findings could potentially lead to better treatment options for individuals with CLL, enhancing their quality of life and prognosis.